Who supplies Merck, who buys from it, and who competes with it. Membership is a disclosed business relationship, not a keyword match, and every row carries the sentence that proves it.
⚡
Supply Chain & Partner Read-Through EngineActive
Proactive revenue read-through alerts whenever Merck files 8-Ks, announces contracts, or beats guidance.
16 companies with a disclosed relationship to Merck · 1 asserted but unconfirmed, hidden
| Ticker | Relationship | Role | Price | Market Cap | P/E | 1D | From High | Mentions | Catalyst Materiality | Alert |
|---|---|---|---|---|---|---|---|---|---|---|
| Distribution (3) | ||||||||||
| CAH | Drug wholesale and distribution | channel | - | - | - | - | - | 24 | 15% exp77 | |
| MCK | Drug wholesale and distribution | channel | - | - | - | - | - | 10 | 15% exp77 | |
| COR | Drug wholesale and distribution | channel | - | - | - | - | - | 9 | 15% exp77 | |
| Payers & PBMs (3) | ||||||||||
| UNH | Coverage | channel | - | - | - | - | - | 11 | 15% exp77 | |
| CVS | PBM formulary | channel | - | - | - | - | - | 9 | 15% exp77 | |
| CI | PBM formulary | channel | - | - | - | - | - | 5 | 15% exp77 | |
| Bioprocessing & Supplies (3) | ||||||||||
| BDX | Injection systems | supplier | - | - | - | - | - | 8 | 15% exp77 | |
| TMO | Bioprocessing and manufacturing | supplier | - | - | - | - | - | 7 | 15% exp77 | |
| WST | Delivery components | supplier | - | - | - | - | - | 7 | 15% exp77 | |
| Clinical Research (2) | ||||||||||
| ICLR | Clinical research | supplier | - | - | - | - | - | 8 | 15% exp77 | |
| IQV | Clinical trials | supplier | - | - | - | - | - | 1 | 15% exp77 | |
| Competitor (5) | ||||||||||
| BMY | Oncology | competitor | - | - | - | - | - | 123 | 20% exp79 | |
| JNJ | Oncology | competitor | - | - | - | - | - | 71 | 20% exp79 | |
| LLY | Broad pharma | competitor | - | - | - | - | - | 57 | 20% exp79 | |
| AMGN | Oncology | competitor | - | - | - | - | - | 4 | 15% exp77 | |
| PFE | Oncology and vaccines | competitor | - | - | - | - | - | 1 | 15% exp77 | |
Every row is backed by a quote from an earnings call or an SEC filing. Mentions counts how often the relationship is named across the last four quarters, which is why the most dependent companies sort to the top of each group. Catalyst Materiality computes hardware bottleneck exposure and priority.